Comparison of Cantharidin Toxicity in Breast Cancer Cells to Two Common Chemotherapeutics
As part of a larger study synthesizing a more directed form of chemotherapy, we have begun to assess the efficacy of different potential toxins that could be delivered locally rather than systemically. In doing so, we hope to reduce the systemic side effects commonly observed, while maintaining a hi...
Saved in:
Main Authors: | Katie M. Kern, Jennifer R. Schroeder |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2014/423059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitosan-Based Nanogel Enhances Chemotherapeutic Efficacy of 10-Hydroxycamptothecin against Human Breast Cancer Cells
by: Hui Guo, et al.
Published: (2019-01-01) -
Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
by: Caitlin M. Tressler, et al.
Published: (2025-03-01) -
Longitudinal Raman Spectroscopic Observation of Skin Biochemical Changes due to Chemotherapeutic Treatment for Breast Cancer in Small Animal Model
by: Myeongsu Seong, et al.
Published: (2017-01-01) -
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
by: R. M. Hayes, et al.
Published: (2024-09-01) -
Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks
by: Muhammad Ayaz, et al.
Published: (2022-01-01)